Silvio Danese to Antirheumatic Agents
This is a "connection" page, showing publications Silvio Danese has written about Antirheumatic Agents.
Connection Strength
0.075
-
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017 12 23; 390(10114):2779-2789.
Score: 0.060
-
Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents. BioDrugs. 2017 Jun; 31(3):223-237.
Score: 0.015